RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-554

  1. 2,282 Posts.
    lightbulb Created with Sketch. 1205
    "I’m thinking we get an answer on Friday US time
    as to whether the evidence is enough to
    be deemed a resubmission. Plus whether
    it is Class 1 or Class 2.

    My opinion - don’t give a stuff what the naysayers
    are on about.

    Friday - end of 14 day turnaround as stated by CBER"



    You've changed your thinking since the 3rd of October in your post 63998141 then.

    CBER has not changed the relevant SOPP 8405.1 or the definition of a BLA resubmission
    ("that purports to answer all the deficiencies that need to be addressed by the applicant
    before approval as set forth in the CR letter") and MSB haven't changed or updated their
    announcement where a major milestone was mentioned but no such purporting of
    answering all deficiencies was made.

    Pity there isn't a practical way to have a side bet with you.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.36
Change
-0.070(2.88%)
Mkt cap ! $3.020B
Open High Low Value Volume
$2.40 $2.42 $2.34 $8.337M 3.518M

Buyers (Bids)

No. Vol. Price($)
1 6198 $2.36
 

Sellers (Offers)

Price($) Vol. No.
$2.37 5376 2
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.